Therapeutic Applications of Curcumin in Diabetes: A Review and Perspective

Cristina Quispe(Arturo Prat University), Jesús Herrera‐Bravo(Universidad de La Frontera), Zeeshan Javed(Lahore Garrison University), Khushbukhat Khan(National University of Sciences and Technology), Shahid Raza(Lahore Garrison University), Zehra Gulsunoglu‐Konuskan(Istanbul Aydın University), Sevgi Durna Daştan(Sivas Cumhuriyet Üniversitesi), Oksana Sytar(Slovak University of Agriculture in Nitra), Miquel Martorell(University of Concepción), Javad Sharifi‐Rad(Universidad del Azuay), Daniela Călina(University of Medicine and Pharmacy of Craiova)
BioMed Research International
January 1, 2022
Cited by 90Open Access
Full Text

Abstract

Diabetes is a metabolic disease with multifactorial causes which requires lifelong drug therapy as well as lifestyle changes. There is now growing scientific evidence to support the effectiveness of the use of herbal supplements in the prevention and control of diabetes. Curcumin is one of the most studied bioactive components of traditional medicine, but its physicochemical characteristics are represented by low solubility, poor absorption, and low efficacy. Nanotechnology-based pharmaceutical formulations can help overcome the problems of reduced bioavailability of curcumin and increase its antidiabetic effects. The objectives of this review were to review the effects of nanocurcumin on DM and to search for databases such as PubMed/MEDLINE and ScienceDirect. The results showed that the antidiabetic activity of nanocurcumin is due to complex pharmacological mechanisms by reducing the characteristic hyperglycemia of DM. In light of these results, nanocurcumin may be considered as potential agent in the pharmacotherapeutic management of patients with diabetes.


Related Papers

No related papers found

Powered by citation graph analysis